James F. Young, Director at NOVAVAX INC (NVAX), sold 24,700 shares at $74.25 ($1.8M) on 2022-03-31, disclosed to the SEC on 2022-04-04.
Open-market sale of $1.8M NVAX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $73.29 | 8,945 | $656K | 36.1% |
| 2 | $73.29 | 8,945 | $656K | 36.1% |
| 3 | $74.25 | 3,255 | $242K | 13.3% |
| 4 | $74.25 | 3,255 | $242K | 13.3% |
| 5 | $75.10 | 300 | $23K | 1.2% |
| Total | $73.57 avg | 24,700 |
| $1.8M |
| 100% |
| Filing → |
| NVAX | SELL | 2024-06-21 | $190K | — | Filing → |
| NVAX | SELL | 2022-01-04 | $541K | — | Filing → |
| NVAX | SELL | 2021-03-25 | $4.6M | — | Filing → |